相关实验视频

Updated: Jun 20, 2026

Oral Biofilm Formation on Different Materials for Dental Implants

Oral Biofilm Formation on Different Materials for Dental Implants

Published on: June 24, 2018

基于聚乳酸的复合材料的哈迪斯托尼特生物陶赋予了多功能,有利于开发下一代固定植入物

Jiaqi Yang¹, Qianshuo Huang², Zeshe Chen³

¹Bio-nanomaterials and Regenerative Medicine Research Division, Zhejiang-California International Nanosystem Institute, Zhejiang University, #866 Yuhangtang Road, Hangzhou, 310058, Zhejiang Province, P. R. China. zhrgou@zju.edu.cn.

Biomaterials science

|March 10, 2026

概括

这项研究开发了新型的聚乳酸 (PLA) 复合物与哈迪斯托尼特 (HAR) 用于可生物降解的内部固定植入物. 这些增强的PLA/HAR植入物显示出改善的机械性能和显著的抗菌疗效对常见的病原体.

科学领域:

生物材料科学生物材料科学
再生医学是一种再生医学.
整形外科植入物整形外科植入物

背景情况:

聚乳酸 (PLA) 是生物相容和可生物降解的,但其机械性能不足于内部固定.
与植入物相关的感染仍然是再生医学的一个重大挑战.
开发具有抗感染能力的多功能植入物至关重要.

研究的目的:

开发基于聚乳酸 (PLA) 的多功能复合材料,其中包含哈迪斯托尼特 (HAR) 粉末,用于内部固定.
提高PLA植入物的机械性能,生物降解性和抗感染能力.
评估这些复合材料在预防植入物相关感染方面的有效性.

主要方法:

以PLA为基础的复合材料是使用低温化和化混合与哈迪斯托尼特 (HAR) 粉末制造的,有或没有 (Na) 兴奋剂.
机械性能 (拉力强度,屈曲强度,模量) 被评估.
实验室生物降解,骨质干细胞活力和对黄金葡萄球菌和大肠杆菌的抗菌疗效进行了评估.
一个肌肉嵌入模型被用于初步组织学观察耐美西林的金黄色葡萄球菌装载植入物.

主要成果:

将HAR或Na-HAR粉末添加到PLA增强了Young's/弹性模量,特别是12%的Na-HAR.
无机粉末的添加加速了体外生物降解,并改善了骨质干细胞的活力.
对黄金葡萄球菌和大肠杆菌的抗菌疗效超过90%.
组织学观察证实了感染预防,减少炎症,并在软组织模型中刺激血管生成.

结论:

与纯PLA相比,PLA/HAR复合材料提供了更好的机械性能和生物降解性.
这些复合材料显示出显著的抗菌功效,并促进了有利于组织再生的微环境.
开发的PLA/HAR材料显示出临床应用的多功能潜力,特别是在治疗骨损伤感染方面.

更多相关视频

Direct and Indirect Culture Methods for Studying Biodegradable Implant Materials In Vitro

Direct and Indirect Culture Methods for Studying Biodegradable Implant Materials In Vitro

Published on: April 15, 2022

Quasistatic Mechanical Testing for Computer-Aided Design and Manufacturing Occlusal Veneers Cemented to Milled Dentin Analog Material

Quasistatic Mechanical Testing for Computer-Aided Design and Manufacturing Occlusal Veneers Cemented to Milled Dentin Analog Material

Published on: December 20, 2024

相关概念视频

Recombinant DNA

Recombinant DNA

Transgenic Organisms

Transgenic Organisms

Bioavailability Enhancement: Drug Stability Enhancement and GI Retention

Bioavailability Enhancement: Drug Stability Enhancement and GI Retention

Improving a drug's stability in the gastrointestinal (GI) tract is paramount for enhancing its bioavailability and therapeutic effectiveness. Various strategies are employed to protect the drug from the harsh gastric milieu and to ensure its release and absorption at the desired site within the GI tract.Polymer coatings are one such method used to shield drugs from the stomach's acidic environment. By preventing premature drug release, these coatings improve the bioavailability of unstable...

Production of Pharmaceuticals

Production of Pharmaceuticals

Industrial insulin production uses genetically engineered E. coli expressing a proinsulin gene controlled by a tryptophan promoter and containing a methionine linker for later cleavage. The cells also carry ampicillin resistance for selective growth. Seed cultures are stored at −80 °C and production begins by thawing a small amount to inoculate starter cultures, which are progressively scaled to a 50,000-L bioreactor. In the bioreactor, E. coli grow in nutrient-rich media under sterile, tightly...

Bioplastics

Bioplastics

Bioplastics derived from microbial processes present a sustainable alternative to conventional petroleum-based plastics. Among these, polyhydroxyalkanoates (PHAs), particularly polyhydroxybutyrates (PHBs), have emerged as prominent candidates due to their biodegradability and biocompatibility. These polymers are synthesized by a variety of bacteria, such as Cupriavidus necator and Pseudomonas putida, which naturally accumulate PHAs as intracellular carbon and energy reserves, especially under...